Proteome Sciences this week entered into a non-exclusive licensing deal allowing Sigma-Aldrich to continue selling products under the ProteoPrep name in Europe, Japan, and Australia.
Sigma-Aldrich has been selling immunodepletion kits under ProteoPrep name, which is a trademark registered to Proteome Sciences in the three geographies covered by this week's announcement.
Currently, Sigma-Aldrich sells 11 ProteoPrep kits. The license includes those products and all future products containing chemicals and reagents for disrupting cells, tissues, or other biological material, and the extraction of biological molecules such as proteins, lipids, and carbohydrates.
The deal also covers methods and processes related to assays for diagnosing disease, as well as chemical markers for determining proteins and peptides by disruption of cells, tissues, and other biological materials, and for targeting drugs.
Proteome Sciences received a signing fee and will receive royalties on product sales. Other financial terms of the deal were not disclosed.